Combined oral contraceptive pills still reduce the risk of ovarian cancer

One in five ovarian tumours may be prevented by taking the modern pill

Women using contemporary hormonal contraception can be reassured their risk of developing ovarian cancer is as low as those taking older versions of the products, researchers say.

The Danish group has shown that using newer combined oral contraceptive pills (COCPs) is associated with a lower risk of developing ovarian cancer compared with no use, and the protective effect strengthens over time.

The newer products have lower doses of oestrogen and use newer progestogens, such as desogestrel, gestodene and drospirenone, the authors said.